- Home
- LTBR vs INBX Comparison
LTBR vs INBX Comparison
Compare LTBR & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTBR
- INBX
- Stock Information
- Founded
- LTBR 1992
- INBX 2010
- Country
- LTBR United States
- INBX United States
- Employees
- LTBR N/A
- INBX N/A
- Industry
- LTBR Professional Services
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- LTBR Consumer Discretionary
- INBX Health Care
- Exchange
- LTBR Nasdaq
- INBX Nasdaq
- Market Cap
- LTBR 397.8M
- INBX 345.8M
- IPO Year
- LTBR N/A
- INBX 2020
- Fundamental
- Price
- LTBR $15.58
- INBX $27.19
- Analyst Decision
- LTBR
- INBX Hold
- Analyst Count
- LTBR 0
- INBX 2
- Target Price
- LTBR N/A
- INBX N/A
- AVG Volume (30 Days)
- LTBR 1.2M
- INBX 111.3K
- Earning Date
- LTBR 10-30-2025
- INBX 11-13-2025
- Dividend Yield
- LTBR N/A
- INBX N/A
- EPS Growth
- LTBR N/A
- INBX N/A
- EPS
- LTBR N/A
- INBX N/A
- Revenue
- LTBR N/A
- INBX $1,400,000.00
- Revenue This Year
- LTBR N/A
- INBX N/A
- Revenue Next Year
- LTBR N/A
- INBX N/A
- P/E Ratio
- LTBR N/A
- INBX N/A
- Revenue Growth
- LTBR N/A
- INBX N/A
- 52 Week Low
- LTBR $2.36
- INBX $10.81
- 52 Week High
- LTBR $18.80
- INBX $30.23
- Technical
- Relative Strength Index (RSI)
- LTBR 57.41
- INBX 56.51
- Support Level
- LTBR $13.59
- INBX $27.51
- Resistance Level
- LTBR $14.96
- INBX $28.86
- Average True Range (ATR)
- LTBR 1.01
- INBX 1.49
- MACD
- LTBR -0.05
- INBX -0.19
- Stochastic Oscillator
- LTBR 57.85
- INBX 48.91
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.